DOI:
10.1055/s-00000031
Klinische Monatsblätter für Augenheilkunde
LinksClose Window
References
Lushchyk T, Amarakoon S, Martinez-Ciriano JP. et al.
Bevacizumab in age-related macular degeneration: a randomized controlled trial on the effect of injections every 4 weeks, 6 weeks and 8 weeks.
Acta Ophthalmol 2013;
91: e456-e461
doi:10.1111/aos.12119
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.